HYPERSENSITIVITY IN MOLAR INCISOR HYPOMINERALISATION USING LOW LEVEL LASER IN CHILDREN
Launched by ALEXANDRIA UNIVERSITY · Nov 24, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called Molar Incisor Hypomineralization (MIH), which affects the enamel of certain teeth, making them sensitive and painful. The trial aims to see if low-level laser treatment can help reduce this tooth sensitivity in children aged 6 to 10 who have at least one affected tooth. To participate, children must be healthy and report a specific level of sensitivity in their teeth.
In this study, 45 children will be divided into three groups to receive different treatments, and their tooth sensitivity will be measured before and after the treatment using a simple pain scale. The researchers will also assess how this sensitivity impacts the children's quality of life. It’s important to note that children with certain dental issues or health conditions will not be eligible to join the trial. This study is still in the planning stages and has not started recruiting participants yet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 6-10-year-old children (15).
- • At least one tooth with MIH and DH reported in the occlusal region with sensitivity equal to or greater than 4 on the Visual analogue Scale (VAS).
- • Good overall health (ASA I).
- Exclusion Criteria:
- • First permanent molars with active carious lesions or defective restorations
- • Sufficient dentin loss that requires restorative therapy.
- • Any clinical signs of failure (abscess, fistula).
- • Patients with systemic diseases.
- • Having undergone any professional desensitizing treatment in the previous 6 months.
- • Having used a desensitizing paste in the previous 3 months.
- • Use of anti-inflammatory drugs or analgesics at the time of recruitment.
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported